High Risk HPV Infections | ||||
---|---|---|---|---|
Negative (32) N | Positive (67) N | Odds Ratio (95% CI) | Adjusted Odds Ratio (95% CI)* | |
Years living with HIV | ||||
<2 | 8 | 21 | 1 (ref) | 1 (ref) |
2 to 6) | 12 | 13 | 2.4 (0.8 – 7.5) | 3.0 (0.5 – 18.5) |
6+ | 12 | 33 | 2.5 (0.9 – 7.1) | 1.7 (0.3 – 9.2) |
Duration of HAART therapy | ||||
<3 | 12 | 42 | 1 (ref) | 1 (ref) |
3+ | 20 | 25 | 0.4 (0.1 – 0.9) | 0.4 (0.1 – 1.4) |
CD4 count | ||||
<400 | 11 | 57 | 1 (ref) | 1 (ref) |
400+ | 21 | 10 | 0.1 (0.03 – 0.2) | 0.2 (0.05 – 0.8) |
HIV viral load | ||||
<50 | 23 | 22 | 1 (ref) | 1 (ref) |
50 – 28,000 | 8 | 26 | 3.4 (1.3 – 9.1) | 1.9 (0.5 – 7.2) |
>28,000 | 1 | 19 | 19.9 (2.4 – 161.3) | 2.2 (0.2 – 25.9) |
Cervical cytology | ||||
Negative | 29 | 25 | 1 (ref) | 1 (ref) |
ASCUS | 1 | 6 | ||
LGSIL | 2 | 29 | ||
HGSIL | 0 | 6 |